Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018 Year: 2018
Towards individualised medicine for airways disease: identifying clinical phenotype groups Source: Eur Respir J 2012; 39: 1033-1034 Year: 2012
A personalised medicine approach to ICS use in COPD Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009
The future of personalised medicine in COPD Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016
Defining acute asthma severity – how do worldwide asthma guidelines compare? Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018
Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021
Defining asthma–COPD overlap syndrome: a population-based study Source: Eur Respir J, 49 (5) 1602008; 10.1183/13993003.02008-2016 Year: 2017
Narrative medicine to evaluate the relationship between clinicians and patients living with severe asthma Source: International Congress 2017 – Medical education, web and internet Year: 2017
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
Understanding patients' needs: the impact of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Adding biological markers to COPD categorisation schemes: a way towards more personalised care? Source: Eur Respir J 2016; 47:1601-1605 Year: 2016
Evaluation of the use of e-learning in training management of asthma and COPD in general medicine. Source: International Congress 2017 – Medical education, web and internet Year: 2017
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
What is new in paediatric asthma? Source: Annual Congress 2006 - Paediatric year in review Year: 2006
In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 Year: 2021
Does usage of eHealth improve symptoms of COPD patients? Source: International Congress 2019 – M-health/e-health II Year: 2019